The UTILE Project, funded by the European Commission, hosted the UTILE London Partnering Summit on July 11 at White City Place in London.
It was a special, customized event, that presented a selection of projects and start-up companies to an audience of investors, industry representatives, advisors, serial entrepreneurs and experts in intellectual property, business development, financing, strategy and venture capital.
4 projects were presented by representatives from institutions in the UK, Ireland, France, and Finland. These included offerings in regenerative medicine (AUTOSTEM, Ireland), Sepsis rapid diagnostics (FAEPIC, UK), disease modifying treatment for Parkinson’s disease (Genecode, Finland), and predictive biomarkers for personalized treatment of oncology (RAIDS Network, France).
These projects were among some 50 considered to have high value for eventual commercialization, as evaluated by 4 of Europe’s leading technology transfer offices, (LifeArc, Karolinska Innovations Institutet, Ascenion GmbH, and Bergen BTO), from among approximately 1200 health research projects which received European funding under FP7 or Horizon 2020 Research & Innovation Funding Programme.
Improve the exploitation potential of research results for ended health-related EC-funded projects
UTILE project aims at carrying forward FP7 Health and Horizon2020 SC1 project results by set of online and offline tools such as trainings, workshops and brokerage events. The London Partnering Summit was one of these opportunities specifically organized to provide support to and engagement with high quality projects to support their translational, valorization and commercialization objectives.
In the morning they participated in workshops led by experts in Intellectual Property strategy (Kevin Noonan, and Paul Tuly, Partners, McDonnell Boehnen Hulbert & Berghoff LLP, Chicago, USA), in Business Development and partnering with Industry (Mark Wilson, Managing Director, Strategic Technology Bioconsulting, London, UK0, and Understanding and raising Venture Capital (James Baillieu, Corporate Partner, Bird & Bird, London UK). In the afternoon, the 4 projects presented to the audience and engaged in detailed Q&A followed by direct recommendations and advice from the experts present, after which informal one 2 one meetings took place during the afternoon coffee break and end of day networking reception. Reactions were highly positive, and the projects indicated interest to participate in additional UTILE support initiatives prior to the end of the project in December 2019.
Organized by TTS Global Initiative on behalf of the UTILE Health Consortoium, thanks are extended to MedCity, Mitsui Fudosan, MBHB LLP, Bird & Bird, and Europe Unlimited for their support in making this non-commerciali, free access event a reality.
Next opportunity in October 2019, in Trieste (Italy)
Next UTILE event will be organized in October 2019 in the framework of the sixth Meet in Italy for Life Sciences – MIT4LS2019, the leading international conference and matchmaking event for Life Sciences which will be held in Trieste from 16-18 October, at Magazzino Molo IV. Interested projects and companies are encouraged to contact Youssef Sabbah (E-Unlimited) firstname.lastname@example.org to request an invitation and free access and presentation to the investors, experts and industry representatives who will be present during the event. MIT4LS2019 is an important for a where the latest innovations in the Biotech field, Medtech and e-Health sectors will be presented.
Watch the video of the UTILE workshop organized during the MIT4LS2018!
For more information read the press release here.